sr 95531 has been researched along with Disease Exacerbation in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birnir, B; Groop, L; Jin, Y; Jin, Z; Korsgren, O; Lang, S; Muhammed, SJ; Renström, E; Salehi, A; Taneera, J; Zhang, E | 1 |
1 other study(ies) available for sr 95531 and Disease Exacerbation
| Article | Year |
|---|---|
γ-Aminobutyric acid (GABA) signalling in human pancreatic islets is altered in type 2 diabetes.
Topics: Diabetes Mellitus, Type 2; Disease Progression; Dose-Response Relationship, Drug; Down-Regulation; Female; GABA Antagonists; gamma-Aminobutyric Acid; Homeostasis; Humans; Immunohistochemistry; Insulin-Secreting Cells; Male; Middle Aged; Pyridazines; Receptors, GABA-B; Signal Transduction | 2012 |